HIGHLIGHTS
- who: Omicron Variant et al. from the USA USA have published the research work: Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA, in the Journal: (JOURNAL)
SUMMARY
Antibodies to SARS-CoV-2 infection may be present as early as 10 days postinfection, but the presence of antibodies alone is an incomplete predictor of protection. Cross-reactive immunity after COVID-19 illness and SARS-CoV-2 vaccination has been shown to confer broad protection against heterologous coronaviruses. This protection, however, might be variable depending on variants. Convalescent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.